ICUI
Price
$173.93
Change
-$0.88 (-0.50%)
Updated
Nov 14, 03:25 PM (EDT)
110 days until earnings call
NEOG
Price
$14.87
Change
-$0.32 (-2.11%)
Updated
Nov 14, 03:31 PM (EDT)
33 days until earnings call
Ad is loading...

ICUI vs NEOG

Header iconICUI vs NEOG Comparison
Open Charts ICUI vs NEOGBanner chart's image
ICU Medical
Price$173.93
Change-$0.88 (-0.50%)
Volume$119
CapitalizationN/A
Neogen
Price$14.87
Change-$0.32 (-2.11%)
Volume$1.03K
CapitalizationN/A
ICUI vs NEOG Comparison Chart
Loading...
ICUI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ICUI vs. NEOG commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a StrongSell and NEOG is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (ICUI: $174.81 vs. NEOG: $15.19)
Brand notoriety: ICUI and NEOG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICUI: 230% vs. NEOG: 122%
Market capitalization -- ICUI: $2.55B vs. NEOG: $3.42B
ICUI [@Medical Specialties] is valued at $2.55B. NEOG’s [@Medical Specialties] market capitalization is $3.42B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICUI’s FA Score shows that 1 FA rating(s) are green whileNEOG’s FA Score has 1 green FA rating(s).

  • ICUI’s FA Score: 1 green, 4 red.
  • NEOG’s FA Score: 1 green, 4 red.
According to our system of comparison, both ICUI and NEOG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICUI’s TA Score shows that 3 TA indicator(s) are bullish while NEOG’s TA Score has 4 bullish TA indicator(s).

  • ICUI’s TA Score: 3 bullish, 6 bearish.
  • NEOG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NEOG is a better buy in the short-term than ICUI.

Price Growth

ICUI (@Medical Specialties) experienced а -2.35% price change this week, while NEOG (@Medical Specialties) price change was -2.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.85%. For the same industry, the average monthly price growth was +1.00%, and the average quarterly price growth was -4.44%.

Reported Earning Dates

ICUI is expected to report earnings on Mar 04, 2025.

NEOG is expected to report earnings on Dec 17, 2024.

Industries' Descriptions

@Medical Specialties (-1.85% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEOG($3.42B) has a higher market cap than ICUI($2.55B). ICUI has higher P/E ratio than NEOG: ICUI (333.33) vs NEOG (150.80). ICUI YTD gains are higher at: 75.266 vs. NEOG (-24.465). ICUI has higher annual earnings (EBITDA): 253M vs. NEOG (189M). ICUI has more cash in the bank: 255M vs. NEOG (230M). NEOG has less debt than ICUI: NEOG (889M) vs ICUI (1.7B). ICUI has higher revenues than NEOG: ICUI (2.26B) vs NEOG (919M).
ICUINEOGICUI / NEOG
Capitalization2.55B3.42B75%
EBITDA253M189M134%
Gain YTD75.266-24.465-308%
P/E Ratio333.33150.80221%
Revenue2.26B919M246%
Total Cash255M230M111%
Total Debt1.7B889M192%
FUNDAMENTALS RATINGS
ICUI vs NEOG: Fundamental Ratings
ICUI
NEOG
OUTLOOK RATING
1..100
513
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
85100
SMR RATING
1..100
8888
PRICE GROWTH RATING
1..100
3850
P/E GROWTH RATING
1..100
23
SEASONALITY SCORE
1..100
n/a4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICUI's Valuation (91) in the Medical Specialties industry is in the same range as NEOG (96). This means that ICUI’s stock grew similarly to NEOG’s over the last 12 months.

ICUI's Profit vs Risk Rating (85) in the Medical Specialties industry is in the same range as NEOG (100). This means that ICUI’s stock grew similarly to NEOG’s over the last 12 months.

ICUI's SMR Rating (88) in the Medical Specialties industry is in the same range as NEOG (88). This means that ICUI’s stock grew similarly to NEOG’s over the last 12 months.

ICUI's Price Growth Rating (38) in the Medical Specialties industry is in the same range as NEOG (50). This means that ICUI’s stock grew similarly to NEOG’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is in the same range as NEOG (3). This means that ICUI’s stock grew similarly to NEOG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICUINEOG
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 9 days ago
68%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
ICUI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIEDX8.57N/A
N/A
MassMutual International Eq R5
HCPCX54.45N/A
N/A
Hartford Capital Appreciation HLS IC
RNPBX61.29-0.17
-0.28%
American Funds New Perspective R2
VMCRX6.03-0.03
-0.50%
Voya MidCap Opportunities Port R6
DGEYX21.32-0.14
-0.65%
BNY Mellon Global Emerging Mkts - Y

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with LMAT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then LMAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
-1.80%
LMAT - ICUI
46%
Loosely correlated
-0.62%
RVTY - ICUI
46%
Loosely correlated
-0.51%
TFX - ICUI
44%
Loosely correlated
-0.82%
NEOG - ICUI
44%
Loosely correlated
-0.98%
CERS - ICUI
43%
Loosely correlated
-2.12%
More

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with CRL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
-0.98%
CRL - NEOG
47%
Loosely correlated
-4.35%
AZTA - NEOG
45%
Loosely correlated
-3.24%
VCYT - NEOG
44%
Loosely correlated
+3.37%
MASS - NEOG
42%
Loosely correlated
-19.86%
BLFS - NEOG
42%
Loosely correlated
-9.02%
More